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Summary
The distribution of PBP5, the major D,D-
carboxypeptidase in Escherichia coli, was mapped by
immunolabelling and by visualization of GFP fusion
proteins in wild-type cells and in mutants lacking one
or more D,D-carboxypeptidases. In addition to being
scattered around the lateral envelope, PBP5 was also
concentrated at nascent division sites prior to visible
constriction. Inhibiting PBP2 activity (which elimi-
nates wall elongation) shifted PBP5 to midcell,
whereas inhibiting PBP3 (which aborts divisome
invagination) led to the creation of PBP5 rings at posi-
tions of preseptal wall formation, implying that
PBP5 localizes to areas of ongoing peptidoglycan
synthesis. A PBP5(S44G) active site mutant was more
evenly dispersed, indicating that localization required
enzyme activity and the availability of pentapeptide
substrates. Both the membrane bound and soluble
forms of PBP5 converted pentapeptides to tetrapep-
tides in vitro and in vivo, and the enzymes accepted
the same range of substrates, including sacculi, Lipid
II, muropeptides and artiﬁcial substrates. However,
only the membrane-bound form localized to the devel-
oping septum and restored wild-type rod morphology
to shape defective mutants, suggesting that the two
events are related. The results indicate that PBP5
localization to sites of ongoing peptidoglycan synthe-
sis is substrate dependent and requires membrane
attachment.
Introduction
The morphology of most bacteria is determined by the
interplay of cytoskeleton-like proteins with enzymes that
fabricate the peptidoglycan cell wall, although the mecha-
nisms by which any one cell shape is created and main-
tained remain largely undeﬁned (Den Blaauwen et al.,
2008; Vollmer and Bertsche, 2008). The peptidoglycan
layer of Escherichia coli (E. coli) is a covalently closed
network of sugar strands that are interconnected by
peptide side bridges. The peptidoglycan-building unit, the
disaccharide pentapeptide N-acetyl-glucosamine-b-1,4-
N-acetyl-muramyl pentapeptide, is inserted into the exist-
ing peptidoglycan layer by the combined synthetic and
hydrolytic activities of the penicillin-binding proteins
(PBPs). The hydrolytic activity of PBPs is necessary for
cell growth, because the covalent bonds of the peptidogly-
can layer have to be broken for the insertion of new
subunits (Vollmer and Bertsche, 2008). The pentapeptide
consists of L-Ala-g-D-Glu-m-A2pm-D-Ala-D-Ala, where
m-A2pm stands for meso-diaminopimelic acid. Peptidogly-
can polymer synthesis is catalysed by high molecular
mass PBPs, of which the Class A types possess both
transglycosylase and transpeptidase activities that extend
the glycan chains and cross-link the peptide side bridges
(PBP1A, PBP1B and PBP1C), and the Class B types
possess only transpeptidase activity (PBP2 and PBP3)
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© 2010 Blackwell Publishing Ltd(Sauvage et al., 2008). In the transpeptidase reaction, the
amino group of m-A2pm and the carbonyl group of D-Ala
residues of adjacent glycan strands are coupled to form a
peptide cross bridge, while concomitantly releasing the
terminal D-Ala from the donor peptide strand. Low molecu-
lar mass Class C PBPs have either D,D-carboxypeptidase
activity (PBP5, PBP6 and PBP6B/DacD), which removes
the terminal D-Ala of the pentapeptide chain in a reaction
similar to transpeptidation, or else they have endopepti-
dase activity (PBP4 and PBP7), which cleaves the peptide
cross bridges (Ghosh et al., 2008).
The structure of the most abundant D,D-
carboxypeptidase PBP5 (Fig. S1) consists of two
modules oriented ~90° to one another (Davies et al.,
2001; Nicholas et al., 2003). Module I (amino acids
1–262) contains the D,D-carboxypeptidase active site,
which is situated at the interface of a ﬁve-stranded anti-
parallel b-sheet packed on both sides by a helices.
Module II (amino acids 263–374) consists of two antipar-
allel b-sheets plus an amphipathic carboxy-terminal helix,
with this latter being responsible for attaching PBP5 to the
cytoplasmic membrane (Pratt et al., 1986; Phoenix and
Pratt, 1990). (Note that the amino acid numbering for
PBP5 does not include the original residues 1–29, which
represent the signal sequence that is cleaved once the
protein is translocated to the periplasm.)
E. coli mutants lacking PBP5 show a variety
of morphological defects such as branches, bends
and kinks (Young, 2003). Deletion of the other D,D-
carboxypeptidases enhances these morphological aber-
rations, which can subsequently be corrected by the
expression of PBP5 (Nelson and Young, 2001). The gene
for the 41.6 kDa protein PBP5 (dacA) is part of an operon
that also contains the genes coding for PBP2 and RodA
(pbpA/mrdA and rodA/mrdB respectively) (Stoker et al.,
1983), proteins that are both essential for cell elongation.
Overproduction of PBP5 in normal rod-shaped cells
results in spherical growth (Markiewicz et al., 1982) and
has been claimed to restore cell division at the non-
permissive temperature in cells carrying the ftsI23 allele,
which produces a temperature sensitive version of PBP3
(Begg et al., 1990). Curiously, the temperature sensitive
phenotype of the missense mutations ftsK44 and
ftsK3531 are suppressed by deleting the dacA gene
(Begg et al., 1995; Draper et al., 1998). These observa-
tions suggest that PBP5 may play a role in balancing the
growth of cell length versus septal peptidoglycan
synthesis. This putative regulatory role is not exerted by a
ﬂuctuating concentration of PBP5 during the cell cycle,
which appears to be constant (Wientjes et al., 1983), hov-
ering near 317  69 molecules per cell when grown in M9
minimal medium and 790  105 molecules per cell when
grown in rich medium (Dougherty et al., 1996). An alter-
nate possibility is that the cellular localization of PBP5
varies over the cell cycle and helps to regulate peptidogly-
can synthesis.
We analysed the localization of endogenous PBP5 in
mutants defective in elongation or cell division, by using
immunolocalization and by visualizing GFP-PBP5 fusion
proteins in live cells. PBP5 localized in the cylindrical
envelope as well as at the division site, and the amount of
PBP5 at these sites correlates with the location and inten-
sityofpeptidoglycansynthesis.Theselocalizationpatterns
were lost when the active site serine of PBP5 was mutated
or when the membrane-associated, carboxy-terminal
amphipathic helix was removed. We conclude, ﬁrst, that
PBP5 localization depends on the continued synthesis of
peptidoglycan instead of requiring direct interactions with
proteins comprising the peptidoglycan-polymerizing
machinery, and second, that the morphological function of
periplasmic PBP5 requires a deﬁned interaction between
PBP5 and the inner membrane that enables the protein to
localize properly at the division septum.
Results
PBP5 localizes in the lateral envelope and at septal
constrictions
PBP5 affinity-puriﬁed antiserum recognized PBP5 as well
as PBP6 on immunoblots and showed an envelope local-
ization pattern in dacA deletion strains, which are devoid
of PBP5 (data not shown). These results indicated that at
least some of the antibodies were cross-reactive. To elimi-
nate these antibodies, the affinity-puriﬁed antiserum was
incubated with a cell extract derived from the dacA dele-
tion strain E. coli CS12-7. This step removed cross-
reactive antibodies against PBP6 and allowed antibodies
against PBP5 to remain in the supernatant. The proce-
dure yielded an IgG fraction that recognized a single band
on an immunoblot with a mass that corresponded to that
of PBP5 (Fig. S2D) and that showed no staining in the
dacA deletion strain CS12-7 (Fig. S2B) or in strain
CS703-1 (Fig. S2C), which lacks PBP 1A, 4, 5, 6 and 7, as
well as the AmpC b-lactamase and the AmpH
b-lactamase-like protein (Denome et al., 1999). This latter
strain grows with a severely aberrant morphology
(Denome et al., 1999; Meberg et al., 2001) that is comple-
mented by the expression of active PBP5 (Nelson and
Young, 2000; 2001). In the parental strain, E. coli CS109,
PBP5 localized as foci in the lateral wall, with very few foci
at the old cell poles but somewhat more pronounced at
midcell (Fig. S2Aand E). This IgG fraction was used for all
further studies of the localization pattern of PBP5.
An sfGFP-PBP5 fusion protein is functional and
localizes to division sites
To conﬁrm the immunolocalization pattern of PBP5 in
living cells, we fused green ﬂuorescent protein (GFP) to
PBP5 localizes at peptidoglycan synthesis sites 301
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 300–323PBP5 so that the fusion protein would be transported to
the periplasm. In Gram-negative bacteria, when wild-type
GFP is exported to the periplasm via the general secretion
(Sec) pathway the protein does not fold correctly and
does not become ﬂuorescent (Feilmeier et al., 2000).
However, previous work showed that pre-folded GFP and
proteins fused to GFP were exported to the periplasm via
the twin-arginine transport pathway (Bernhardt and de
Boer, 2003; 2004). With this expectation, we created a
TorA-GFP-PBP5 fusion protein in an attempt to determine
the localization of ﬂuorescently tagged PBP5 in live cells.
Unfortunately, this GFP-PBP5 protein was not exported to
the periplasm, for reasons that are under investigation
(L. Potluri, H. Lavender and K.D. Young, unpublished). To
circumvent this problem, we fused PBP5 to a newly
created enhanced folding variant of GFP, superfolder GFP
(sfGFP), which is exported by the SRP pathway and folds
properly to become ﬂuorescent in the periplasm (Uehara
et al., 2009). We constructed a dsbA(SS)-sfgfp-dacA
gene that encodes an sfGFP-PBP5 fusion protein with the
signal sequence of DsbA at its amino terminus. To deter-
mine if this protein was exported to the periplasm, we
placed the gene under control of the lac promoter in a
medium copy plasmid, pLP4, and expressed the protein in
E. coli CS703-1. The DsbA(SS)-sfGFP-PBP5 protein was
highly ﬂuorescent and complemented the shape defects
of CS703-1 so that the cells grew with virtually normal
rod-shaped morphology and the PBP5 fusion protein was
distributed around the cell periphery, appearing as a thin
ﬂuorescent line studded with numerous bright spots
(Fig. 1A). Cells in the process of division (constricting
cells) also exhibited bright rings or spots at the septa
(Fig. 1A). In addition, a faint ﬂuorescent band appeared at
the centre of some of the elongated cells that had not yet
formed a visible constriction (Fig. 1). The same localiza-
tion pattern was observed when DsbA(SS)-sfGFP-PBP5
was expressed in the parental strain CS109 (Fig. 1B).
These localization patterns paralleled the distribution of
PBP5 as determined by immunoﬂuorescence (see
Fig. S2 and below).
PBP5 localization at the division site requires the
presence of FtsZ
The formation of the FtsZ ring at the middle of the cell is
the earliest known step of cell division. Once the FtsZ ring
is formed (Den Blaauwen et al., 1999), after about one-
ﬁfth of a generation time, other proteins are recruited
(Aarsman et al., 2005) and together they form the multi-
protein divisome complex (Nanninga, 1991). The age at
which a protein starts to localize at midcell can be calcu-
lated from the fraction of cells that show protein midcell
localization in steady state grown cells (Den Blaauwen
et al., 1999). The timing of divisome maturation is well
established in E. coli LMC500, so we visualized PBP5 by
immunostaining ﬁxed cells of this strain after growing to
steady state in GB1 medium at 28°C. PBP5 localized in a
spot-like pattern in the lateral envelope and more densely
at the division site of constricting cells (Fig. 2A). The
average ﬂuorescence signal along the normalized cell
length of about 140 cells showed a clear increase in the
ﬂuorescence signal at midcell of constricting cells
(Fig. 2B). The increase in intensity at midcell was not a
result of membrane constriction, i.e. merely due to a
double layer of membrane [compare the ﬂuorescence
intensity proﬁle of membranes labelled with the general
Fig. 1. sfGFP-PBP5 is a functional fusion
and localizes to active
peptidoglycan-synthesizing regions.
A. sfGFP-PBP5 complements the cell shape
defects of E. coli CS703-1, which lacks the
three major D,D-carboxypeptidases, and
localizes to the cell periphery and to septa of
constricting cells.
B. A Similar localization pattern was observed
in the parent strain, CS109. Phase contrast
images are on the left and ﬂuorescence
images are on the right. All images have the
same magniﬁcation, and the scale bar in
panel B equals 5 mm.
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Bertsche et al. (Bertsche et al., 2006)].
To determine whether midcell localization of PBP5
depended on speciﬁc divisome proteins, we visualized
PBP5 in E. coli LMC509, which expresses the
FtsZ84(ts) protein. This temperature-sensitive FtsZ
variant does not polymerize when cells are grown at the
restrictive temperature of 42°C. As a result, division is
Fig. 2. PBP5 localizes in the lateral cell
envelope and at the division site in the
presence of active FtsZ.
A. Immunolocalization pattern of PBP5 in the
wild-type strain LMC500, which is the parental
strain of all temperature-sensitive strains used
in this study. Phase contrast images are on
the left and ﬂuorescence images are on the
right. Arrows indicate midcell localization. The
bar equals 1 mm.
B. Average ﬂuorescence proﬁles per cell
plotted against their normalized cell length.
The dashed proﬁle is from non-constricting
cells (n = 360) and the solid line from
constricting cells (n = 140).
C. Immunolocalization pattern of PBP5 in the
FtsZ84(ts) strain LMC509 at the restrictive
temperature. Phase contrast images are on
the left and ﬂuorescence images are on the
right. The bar equals 1 mm.
D. Average ﬂuorescence proﬁles per cell
plotted against normalized cell length. The
dashed proﬁle is from ﬁlaments after a shift
for two MDs to 42°C (n = 150) and the solid
line from cells grown to steady state at the
permissive temperature (n = 500). Note that
PBP5 does not localize preferentially at
midcell in the absence of localized FtsZ.
PBP5 localizes at peptidoglycan synthesis sites 303
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 300–323not initiated and the cells grow into ﬁlaments (Addinall
et al., 1997). At 28°C, PBP5 localized in the same
fashion as observed in the parent strain LMC500
(Fig. 2D). However, at 42°C, PBP5 was evenly distrib-
uted in the cell envelope with no pronounced presence
at midcell (Fig. 2C and D). A similar distribution pattern
was observed for the DsbA(SS)-sfGFP-PBP5 fusion
protein (not shown). These results indicate that the
septal localization of PBP5 depends directly or indirectly
on the presence of FtsZ rings.
Localization of PBP5 does not require a
mature divisome
To determine whether PBP5 localization depended on
one or more divisome proteins in addition to FtsZ, we
visualized the distribution of PBP5 in ﬁlamentous FtsA(ts)
cells. FtsA is an essential cell division protein and its
presence is required for the recruitment of the late local-
izing divisome proteins FtsK upto FtsN (Wang and Lut-
kenhaus, 1998; Chen and Beckwith, 2001). The strain
LMC512 that harbours a temperature-sensitive FtsA
mutation (Taschner et al., 1988) and its parental strain
LMC500 were grown to steady state in GB1 medium at
28°C and shifted for two mass doublings (MDs) to the
restrictive temperature of 42°C. The average ﬂuorescence
proﬁles of the immunolabelled LMC500 and LMC512
strains showed a clear lateral wall and midcell localization
of PBP5 at the permissive temperatures (Fig. 3A).
However, at non-permissive temperatures PBP5 localiza-
tion shifted to one quarter and three quarter positions in
the FtsA(ts) ﬁlaments. This localization pattern of PBP5
coincided with the FtsZ localization (Fig. 3A light grey
proﬁle). A similar distribution pattern was observed for the
DsbA(SS)-sfGFP-PBP5 fusion protein (Fig. 3B). These
results suggest that septal localization of PBP5 does not
require mature divisome.
To substantiate these results, PBP5 midcell localization
was investigated in other cell division mutants. PBP3 is
required for septal peptidoglycan synthesis and it local-
izes to the division site during the late stage of divisome
assembly, and remains associated with the divisome until
invagination and septation are completed (Weiss et al.,
1999; Aarsman et al., 2005). E. coli LMC510 contains the
ftsI2158 mutation and expresses a temperature-sensitive
variant of PBP3 that is not able to localize at the restrictive
temperature (Bertsche et al., 2006). After growing the
strain at 42°C for two MDs, LMC510 produced cell ﬁla-
ments with blunt constrictions where septation would nor-
mally occur.
When we utilized the immunolocalization procedure to
locate PBP5 in ﬁlaments produced by inactivating
PBP3(ts), the protein was not observed at midcell or at
other potential division sites (Fig. 4A and C), implying that
the positioning of PBP5 depended on the presence of
PBP3 or, in conﬂict with the conclusion based on the
Fig. 3. PBP5 localizes in FtsA(ts) ﬁlaments
at the same positions as FtsZ localizes.
A. Average ﬂuorescence proﬁles per cell
plotted against their normalized cell length.
The surface below the graphs has been
normalized to 1. wild-type LMC500 cells (dark
grey lines) or LMC512 FtsA(ts) cells (black
lines) grown to steady state in GB1 medium
at the permissive temperature of 28°C (solid
line) and after two MD at 42°C (dotted line)
were immunolabelled with affinity-puriﬁed
antibodies against PBP5. The light grey
proﬁle is from LMC512 cells grown for two
MDs at the restrictive temperature and
immunolabelled with antibodies against FtsZ.
More than 1000 cells were analysed for each
proﬁle.
B. Immunolocalization pattern of PBP5 in the
Strain PS236 (ftsA12) expressing
DsbA(SS)-sfGFP-PBP5 at restrictive
temperature (42°C) for approximately two
MDs. Cells were immediately ﬁxed after
harvest. Phase contrast images are on the left
and ﬂuorescence images are on the right. The
bar equals 5 mm.
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visualized the distribution of PBP5 in E. coli LMC500 in
the presence of aztreonam, which inhibits the activity of
PBP3 (Sykes and Bonner, 1985) but which allows PBP3
to remain at midcell for at least two MDs, after which a few
percent of the cells develop divisomes at the one-quarter
and three-quarter positions of the ﬁlaments (Den Blaau-
wen et al., 2003). If PBP5 localization depends on the
presence of PBP3 but not on its activity, then PBP5 should
localize to midcell even though cell division could not be
completed. Instead, as measured by the immunolocaliza-
tion procedure, PBP5 did not localize at midcell in
aztreonam-induced ﬁlaments after two MDs but appeared
to be distributed randomly around the cell envelope
(Fig. 4B and C). At ﬁrst, this pattern suggested that PBP5
localization needed an active PBP3 protein in the
divisome. However, additional immunolabelling experi-
ments showed that aztreonam-treated cells did have
PBP5 rings when PBP5 was expressed ectopically from a
plasmid (see below).
In the preceding experiments, endogenous PBP5 was
localized in ﬁxed cells by using antibodies to detect the
protein. However, there are cases in which the ﬁxation
protocol for immunolabelling alters or destroys the local-
ization patterns of divisome-related proteins such as
FtsZ, SufI/FtsP and AmiC (Bernhardt and de Boer, 2003;
Peters et al., 2007; Tarry et al., 2009). Thus, the above
procedure may not be as sensitive a localization method
as one based on visualizing the ﬂuorescence produced
by proteins fused to GFP in living cells. Therefore, to
determine if PBP5 localization did indeed depend on a
relatively mature divisome, we followed the distribution
Fig. 4. Immunolocalization does not detect
septal localization of PBP5 when PBP3 is
inactivated.
A. Immunolocalization pattern of PBP5 in the
FtsI2158(ts) strain LMC510 after growth in
GB1 at the restrictive temperature (42°C) for
two MDs.
B. Immunolocalization pattern of PBP5 in the
wild-type strain LMC500 after growth in GB1
at 28°C in the presence of 1 mgm l
-1
aztreonam for two MDs. The bar equals 1 mm.
C. Average ﬂuorescence intensity proﬁles per
average cell plotted against their normalized
cell length. The proﬁle of the black dashed
line is from ﬁlaments after growth for two MDs
in the presence of aztreonam (n = 154), the
proﬁle of the grey dashed line is from
ﬁlaments grown after a shift for two MDs to
42°C (n = 165) and the proﬁle of the solid line
is from LMC510 cells grown to steady state at
the permissive temperature (n = 486). The
ﬂuorescent proﬁles have been shifted with
respect to each other to allow visualization of
the shape of the proﬁles, which would have
overlapped too much if their surface would
have be normalized to 1.
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expressed in aztreonam-induced cell ﬁlaments. In con-
trast to the immunolabelling results, sfGFP-PBP5 local-
ized as a ring at midcell in aztreonam-induced cell
ﬁlaments grown for one MD. After two MDs many ﬁla-
ments lost this midcell PBP5 ring, but in these cases two
additional PBP5 rings appeared where nascent division
sites were positioned at one quarter and at three quar-
ters of the cell length (Fig. 5). To further conﬁrm these
observations, we visualized the distribution of DsbA(SS)-
Fig. 5. DsbA(SS)-sfGFP-PBP5 localizes to
newly forming septa in the absence of active
PBP3.
A. The parent strain CS109 expressing
DsbA(SS)-sfGFP-PBP5 after inactivation of
PBP3 by exposure to 1 mgm l
-1 aztreonam for
one MD.
B. Strain LP10-1 expressing
DsbA(SS)-sfGFP-PBP5 at restrictive
temperature (42°C) for approximately 1.5
MDs. Cells were immediately ﬁxed after
harvest.
C. Strain CS703-1 expressing
DsbA(SS)-sfGFP-PBP5 in the presence of
aztreonam for one MD.
D. Strain CS703-1 expressing
DsbA(SS)-sfGFP-PBP5 in the presence of
aztreonam for two MDs. Arrows (in panel B
and D) indicate older aborted division sites.
E. Strain CS703-1 expressing PBP5 in the
presence of aztreonam for one MD and
immunolabelled with antibodies against PBP5.
The arrows (in panel E) indicate PBP5
localization at midcell, at one-quarter or at
three-quarter positions of the cell. Phase
contrast images are on the left and
ﬂuorescence images are on the right. The
bars equal 5 mm.
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© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 300–323sfGFP-PBP5 in E. coli LMC510 (ftsI2158) and in E. coli
LP10-1 (ftsI23), both of which express temperature sen-
sitive versions of PBP3, and in E. coli LMC531 (ftsQ1),
which expresses a temperature-sensitive FtsQ protein
(van den Ent et al., 2008). Each strain was grown in
GB1 and in TY medium at the permissive temperature of
28°C in the presence of 50 mM IPTG for 1 MD (to
induce expression of the sfGFP-PBP5 protein) and then
shifted to the restrictive temperature of 42°C, for another
one or two MDs (to inhibit divisome assembly at different
points). In all cases, PBP5 localized as a thin ring at
midcell or at the one-quarter and three-quarter positions
in longer cell ﬁlaments (Fig. 5B and Fig. S3). To address
the differences between the results obtained by using
the sfGFP-PBP5 fusion protein versus immunolabelling,
we repeated the immunolabelling experiment with strain
CS703-1, which is rich in pentapeptides, but PBP5 was
expressed from the plasmid pLP515 and PBP3 activity
was inhibited by growing cells in the presence of aztre-
onam for one MD. When these cells were immunola-
belled with antibodies against PBP5, in almost all cells
PBP5 localized at midcell or at the one-quarter and
three-quarter positions of the cell (Fig. 5E). Thus, these
results showed that localization of PBP5 to the septal
ring required the presence of FtsZ but did not require
the presence of proteins that arrive later in divisome
assembly (i.e. FtsK, FtsQ, FtsW, FtsI/PBP3, PBP1B,
FtsN and AmiC).
The difference in results obtained by immunolabelling
of endogenous PBP5 versus those obtained by observ-
ing the GFP-PBP5 fusion protein could be due to the
loss of protein during ﬁxation prior to immunolabelling.
However, when PBP5 was expressed from plasmid
(Fig. 5E) or when we ﬁxed and permeabilized
aztreonam-induced cell ﬁlaments of E. coli CS703-1, the
DsbA(SS)-sfGFP-PBP5 protein was still visible at midcell
(Fig. 5E and data not shown), suggesting that the ﬁxa-
tion procedure did not cause a signiﬁcant loss of PBP5.
We note that GFP-PBP5 produced images in which the
ﬂuorescence was distributed smoothly within the cell
periplasm, whereas immunolabelling with primary and
secondary antibodies produced a coarser, granular
pattern. Because the number of native PBP5 molecules
is 300–700 per cell depending on the growth rate
(Dougherty et al., 1996), we believe the very thin rings of
endogenous PBP5 in cells and cell ﬁlaments were
simply too subtle to be detected by routine immunola-
belling. Consistent with this supposition, in CS703-1, a
pentapeptide-rich strain, we detected PBP5 rings by
immunolabelling when the protein was expressed ectopi-
cally from a plasmid. These results suggest that detect-
ing PBP5 rings with this technique requires a higher
concentration of PBP5 and supports the observations of
sfGFP-PBP5 localization patterns.
PBP5 localization depends on its active site
The affinity of PBP5 for division sites could be because it
interacts with one or more divisome proteins or because it
interacts with its pentapeptide substrate, which is concen-
trated at the septum during cell division. If the interaction
were substrate-dependent, then mutating the active site
of PBP5 should reduce its affinity for pentapeptide and
thus reduce or eliminate PBP5 localization to septal rings,
resulting in an even distribution of PBP5 throughout the
cell envelope. Replacing the active site serine with glycine
at position 44 of PBP5 abolishes all in vitro penicillin
binding as well as its D,D-carboxypeptidase activity (van
der Linden et al., 1994). We constructed the Ser44Gly
(S44G) mutant of PBP5 and expressed the cloned gene
from a low copy number plasmid (pLP514). The D,D-
carboxypeptidase-deﬁcient strain CS703-1 and the wild-
type LMC500 were transformed with pLP514 or with a
plasmid expressing wild-type PBP5 (pLP515). These
were grown in TY medium at 28°C and production of
PBP5(S44G) was induced by addition of 0, 20 or 100 mM
IPTG, after which the cells were grown for two MDs,
harvested and ﬁxed for immunolabelling. As determined
by quantitative immunoblotting, the amount of PBP5
protein produced by these cells was increased by two to
ten-fold compared with PBP5 in uninduced cells (not
shown). At these levels, wild-type PBP5 complemented
the morphological aberrations normally visible in the D,D-
carboxypeptidase-deﬁcient strain CS703-1, whereas the
PBP5(S44G) protein did not complement this phenotype
(not shown). Immunolabelling showed that PBP5(S44G)
was redistributed from its midcell position to the lateral
wall when compared with the localization pattern of wild-
type PBP5 (Fig. 6A), suggesting that PBP5 localization at
midcell depended on its ability to interact with its
substrate.
We sought to conﬁrm this result in live cells by observ-
ing the localization of the active site mutant when fused
to sfGFP. DsbA(SS)-sfGFP-PBP5(S44G) was expressed
in wild-type E. coli,i nt h eDdacA strain CS12-7, and in
the D,D-carboxypeptidase-deﬁcient strain CS703-1. In
all cases, sfGFP-PBP5(S44G) was evenly distributed in
the envelope with either no or very weak ﬂuorescence at
midcell (Fig. 6B and D). Aztreonam-induced cell ﬁla-
ments of these strains did not show any midcell local-
ization of mutant PBP5 despite the presence at midcell
of a mature but inactive divisome (Fig. 6C and E). In
fact, in many cells there was a visible dearth of ﬂuores-
cently labelled sfGFP-PBP5(S44G) protein at sites
where divisomes would be expected to be present
(Fig. 6C and E), as if the mutant protein was avoiding
these sites. The reason for this behaviour is not clear,
but might be due to the inability of this protein to
compete for binding to its substrate.
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PBP5 active site, so it is highly unlikely that this change
alters any putative protein–protein interaction between
PBP5 and one of the divisome proteins. Therefore, we
conclude that PBP5 localization to nascent septa
depends in large measure on its ability to covalently bind
and hydrolyze its pentapeptide substrate present in newly
synthesized peptidoglycan.
Fig. 6. The PBP5(S44G) active site mutant
protein localizes more evenly in the envelope
than the PBP5(wt) protein. Cells were grown
in LB at 30°C for one MD in the presence or
absence of 1 mgm l
-1 aztreonam.
A. Average ﬂuorescence intensity proﬁles
plotted against the normalized cell length of
CS703-1 cells expressing wild-type PBP5
(from pLP515, solid proﬁle) and CS703-1 cells
expressing PBP5(S44G) (from pLP514,
dashed proﬁle). For each proﬁle
approximately 1000 cells were measured.
Representative photographs are shown for
the parent strain CS109 expressing
DsbA(SS)-sfGFP-PBP5(S44G) in the absence
(B) or presence (C) of aztreonam, and for E.
coli CS703-1 expressing DsbA(SS)-sfGFP
PBP5(S44G) in the absence (D) and
presence (E) of aztreonam. Note that the
PBP5(S44G) active site mutant seldom
localizes to septal sites (shown with arrows),
compared with the localization of wild-type
PBP5 (Fig. 5). Phase contrast images are on
the left and ﬂuorescence images are on the
right. The bar equals 5 mm.
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spherical cells
If the localization of PBP5 to the septal ring was being
driven by the location of its pentapeptide substrate, then
the distribution of PBP5 throughout the rest of the peri-
plasmic space might also be determined by active pepti-
doglycan synthesis. To test this idea, we inhibited lateral
cell wall synthesis so that new pentapeptide substrates
would appear only at developing septa. If substrate avail-
ability was important for PBP5 localization, then under
such conditions the majority of PBP5 should relocate to
these division sites.
We inhibited bacterial elongation by interfering with
the function of PBP2, either by inactivating a
temperature-sensitive mutant or by growing cells in the
presence of mecillinam, a speciﬁc inhibitor of PBP2
(Park and Burman, 1973). Both treatments inhibit cell
elongation so that E. coli grows as spherical cells.
E. coli LMC582 carries the chromosomal mutation
pbpa137(ts), which encodes a temperature-sensitive
variant of PBP2 (Woldringh et al., 1988). This strain was
grown in GB1 medium at 28°C until the cells were in log
phase and then the culture was shifted to 42°C for two
MDs, after which the cells were ﬁxed, permeabilized and
labelled with affinity-puriﬁed IgG antibody against PBP5.
The amount of PBP5 was reduced around the circum-
ference of each cell but showed a clear increase in
intensity at midcell sites of ongoing cell division (Fig. 7B
and C solid line). To determine whether the increased
midcell localization of PBP5 was due to the absence of
PBP2 (after thermal inactivation) or due to the lack of
PBP2 enzymatic activity, we monitored the distribution
of PBP5 by immunolocalization in the parent strain
LMC500 after growth in the presence of mecillinam,
which inhibits PBP2 activity without destroying the
protein. LMC500 cells were grown to steady state in
GB1 medium, mecillinam (2 mgm l -1) was added, and
growth was allowed to continue for two MDs. The mor-
phology and PBP5 localization pattern in cells treated
with mecillinam were almost indistinguishable from the
morphology and pattern observed in the thermosensitive
PBP2 strain LMC582 (Fig. 7A and C dashed line). In
these cells, the majority of envelope growth is derived
from the synthesis of the two new cell poles during sep-
tation. Therefore, the similarity of PBP5 localization in
the PBP2(ts) strain and in mecillinam-treated cells sug-
gests that the reduction of PBP5 in the lateral wall
does not reﬂect the absence of intact PBP2 but the
absence of active peptidoglycan synthesis at those
sites. It appears, then, that PBP5 is involved in cell
wall elongation and septation and that the protein
localizes at sites of active and ongoing peptidoglycan
synthesis.
PBP5 localization and function requires its
membrane-anchoring domain
If the presence of pentapeptide substrates was the only
determining factor for the localization of PBP5, then one
would expect that a soluble periplasmic form of PBP5,
which is unable to anchor itself to the inner membrane,
would give the same localization pattern as that produced
by the membrane-bound form of PBP5. To determine if
this was the case, we constructed a PBP5 mutant that
lacked the C-terminal 18 amino acids, which comprise
the membrane-binding amphipathic helix (Pratt et al.,
1986), and fused this construct to DsbA(SS)-sfGFP. The
localization of the fusion protein, DsbA(SS)-sfGFP-
PBP5CD18, was visualized in the parental strain CS109,
in the PBP5 deletion strain CS12-7 and in the D,D-
carboxypeptidases-deﬁcient strain CS703-1 (Fig. 8). In
the parent strain the protein localized evenly along the cell
periphery and showed no preference for localization at the
septum in constricting cells (Fig. 8A). Similar results were
observed when the wild-type cells were treated with aztre-
onam (Fig. 8B). However, in 3% of cells (n = 195) lacking
PBP5 (CS12-7), the DsbA(SS)-sfGFP-PBP5CD18 fusion
protein localized weakly to the septum (data not shown).
Because these two strains contain functional PBP5 and
PBP6 (in CS109) or PBP6 (in CS12-7), it appears that
removing the membrane anchor from PBP5 creates a
protein that cannot compete efficiently with these
membrane-bound D,D-carboxypeptidases for pentapep-
tide substrate at division sites. This interpretation was
reinforced by the localization of DsbA(SS)-sfGFP-
PBP5CD18 in E. coli CS703-1, which contains neither of
these competing enzymes. In this strain, 26% of the cells
(n = 240), showed a faint ﬂuorescent band at the septum
(Fig. 8D) indicating that at least some of the soluble
protein was able to bind its substrate at midcell in the
absence of competing proteins. Thus, we conclude that
the amphipathic membrane anchor is required for optimal
localization of PBP5.
We next asked if changes in the cellular localization of
PBP5 were correlated with its physiological function. For
this purpose we determined whether the ability of PBP5 to
complement the morphological abnormalities of E. coli
CS703-1 was altered by the presence or absence of the
protein’s membrane anchor. We measured the extent of
cell shape deformities by using a Fluorescence Activated
Cell Sorter, which can quantify the relative size and com-
plexity (shape) of bacterial cells. We have previously used
this procedure to identify even minor cell shape differ-
ences among E. coli strains lacking different combina-
tions of PBPs (Meberg et al., 2004). When expressed
in the morphologically complex mutant CS703-1, the
membrane-anchored DsbA(SS)-sfGFP-PBP5 protein
returned this strain to almost completely normal cell
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the active site mutant PBP5(S44G) did not complement
the phenotype, and in fact seemed to make the cells more
aberrant (Fig. S4C). The anchorless DsbA(SS)-sfGFP-
PBP5CD18 protein produced only a slight complementa-
tion of the aberrant morphology in this strain (Fig. S4D,
compared with Fig. S4A). These observations agree with
previous work employing native PBP5 constructs that
were not fused to GFP (Nelson et al., 2002). As stated
previously, when expressed in E. coli CS703-1 cells
grown for one MD in the presence of aztreonam, the
anchorless PBP5CD18 fusion protein localized to midcell
in 26% of the population. However, the anchorless form of
the active site mutant, PBP5(S44G), localized evenly
around the cell periphery but in many cases avoided the
midcell position (Fig. S5), where wild-type PBP5 (or
PBP5CD18) would normally accumulate. This avoidance
mechanism is peculiar and is under investigation, but may
mean that the active site mutant has a greatly reduced
affinity for the kinds of substrates present at the septum.
In any case, the results show that efficient septal localiza-
tion of PBP5 requires both the amphipathic membrane
anchor plus an intact active site.
We conclude that differences in the in vivo function of
PBP5 are not determined solely by its enzymatic activity
but are instead correlated with differences in cellular
localization. Biologically functional PBP5 localizes to sites
of active peptidoglycan synthesis whereas non-functional
Fig. 7. PBP5 localizes predominantly at the
division site in spherical cells.
A. Immunolocalization pattern of PBP5 in the
wild-type strain LMC500 after inhibiting PBP2
by growing cells in the presence of 2 mgm l
-1
mecillinam for two MDs.
B. Immunolocalization pattern of PBP5 in the
PBP2(Ts) strain LMC582 after inactivation of
PBP2 by growing at the restrictive
temperature for two MDs. Phase contrast
images are on the left and ﬂuorescence
images are on the right. The bar equals 1 mm.
C. Average ﬂuorescence proﬁles per cell
plotted against their normalized cell length.
The proﬁle of the dashed line is from the
culture of spherical cells as shown in ‘A’ after
growth for two MDs in the presence of
mecillinam (n = 212). The proﬁle of the solid
line is from spherical cells as shown in ‘B’
after inactivating temperature-sensitive PBP2
by growing at 42°C for two MDs (n = 195).
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particular, PBP5 must be anchored to the outer face of the
inner membrane for the protein to localize properly and be
biologically functional.
PBP5 activity is not very substrate-speciﬁc
Because substrate recognition seemed to be essential for
PBP5 localization, differences in substrate speciﬁcity
might help explain how this enzyme assists in the regu-
lation of cell elongation and division. To determine
whether the difference in physiological function of the
soluble and membrane-bound forms of PBP5 could be
explained by changes in their enzymatic activities, we
examined the substrate speciﬁcity of these proteins
towards a number of artiﬁcial and natural substrates.
The water-soluble form of PBP5 exhibited an active
D,D-carboxypeptidase activity with a clear preference for
UDP-MurNAc-pentapeptide, although substrate S2d
(benzoyl-D-Ala-thiolglycolate, the lateral chain of penicil-
Fig. 8. Septal localization of PBP5 requires
membrane anchoring. Cells were grown in LB
at 30°C in the presence or absence of
1 mgm l
-1 aztreonam for one MD to inactivate
PBP3.
A. wild-type E. coli CS109 expressing the
DsbA(SS)-sfGFP-PBP5CD18 fusion protein
from plasmid pLP523.
B. CS109 expressing the
DsbA(SS)-sfGFP-PBP5CD18 fusion protein in
the presence of aztreonam.




DsbA(SS)-sfGFP-PBP5CD18 fusion protein in
the presence of aztreonam. The left side of
each dual panel is the phase contrast image
and the right side is the ﬂuorescence image.
Panel D contains a mosaic of images taken
from different ﬁelds of view. All images have
same magniﬁcation, and the scale bar in
panel D equals 5 mm.
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reacted with several of these substrates with a kcat
(Table 1) close to the expected kcat of 4 s-1 (Pratt, 2008).
Soluble PBP5 also hydrolyzed lipid II and isolated sacculi
(Fig. S6 and Fig. 9). These results suggest that the
soluble form of PBP5 does not require the disaccharide
moiety of the peptidoglycan-building unit for recognizing
its pentapeptide substrate (see for a review on substrate
speciﬁcity of D,D-peptidases: Pratt, 2008).
To determine if binding to membrane altered the sub-
strates on which PBP5 could act, we removed the signal
sequence from PBP5 and replaced it with an N-terminal
oligo-histidine tag. This His-PBP5 construct remained in
the cytoplasm but retained its C-terminal amphipathic
helix, and the protein was recovered, as expected, in the
membrane fraction of broken cells (not shown). His-PBP5
was puriﬁed by metal affinity chromatography, followed by
removal of the His-tag by cleaving with thrombin and
puriﬁcation by cation exchange chromatography. The
puriﬁed protein (Fig. S7) was incubated with different pos-
sible natural substrates containing D-Ala-D-Ala residues.
This form of PBP5 removed terminal D-Ala residues from
pentapeptides present in peptidoglycan sacculi of strain
D456 (Fig. S7C), from the peptidoglycan precursor lipid II
Fig. 9. Activity of different forms of PBP5 towards whole cell sacculi.
A. In vitro enzymatic activity of soluble PBP5(s) against pentapeptides present in isolated peptidoglycan sacculi. Peptidoglycan sacculi from
strain D456 were incubated with PBP5(s) and digested with cellosyl followed by HPLC analysis of the muropeptide proﬁle. Control is a sample
without PBP5(s). Tetra, disaccharide tetrapeptide; penta, disaccharide pentapeptide; TetraTetra, bis-disaccharide tetratetrapeptide; TetraPenta,
bis-disaccharide tetrapentapeptide.
B. In vivo enzymatic activity of membrane-associated and soluble, periplasmic PBP5 in E. coli cells. Muropeptides from the pentapeptide-rich
strain CS703-1 expressing membrane-associated PBP5 (from plasmid pLP515), soluble, periplasmic PBP5CD18 (from pLP528) or an inactive,
membrane-associated version, PBP5(S44G) (from pLP514), were analysed by HPLC. pLP4 is the empty control plasmid.
Membrane-associated and soluble PBP5 were active against pentapeptides present in sacculi in growing cells.
Table 1. Speciﬁcity proﬁle and kinetic parameters of the hydrolysis
reaction catalysed by puriﬁed water soluble PBP5.
Substrate
a kcat (s
-1)K m (mM) kcat/Km (M
-1 s
-1)
Ac2KAA 2.16 17 130
a AcKAA 0.79 9.5 1.39
UDPMurNAc-pentapeptide 1.93 0.05 27800
S1e 0.17 3.7 40
S2a 3.9 0.6 4800
S2d 24.6 0.74 33000




a. Ac2KAA is bis-acetyl-L-Lys-D-Ala-D-Ala, a AcKAA is a-acetyl-L-
Lys-D-Ala-D-Ala, UDPMurNAc-pentapeptide is L-Ala-g-D-Glu-
mesoA2pm-D-Ala-D-Ala. S stands for CO-C6H5-NH-CHR1-CO-X-
CHR2-COO
-1 with S1e R1 is H, R2 is C6H5-CH2 and X is O. For all
other substrates X is S. For substrate S2a R1 and R2 are an H,
substrate S2c R1 is H and R2 is CH3(D), substrate S2d R1 is CH3(D),
and R2 is H. In case of Val, Leu, or Phe R1 is a mixture of the L and
D amino acid and R2 is H [see also (Wilkin et al., 1994)]. Standard
deviation values are 15% or less.
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MurNAc pentapeptide (not shown). Also, solubilized
pentapeptide-containing muropeptides from strain D456
were digested quantitatively (not shown). Monomeric and
dimeric (cross-linked) pentapeptides in sacculi as well as
individual monomeric and dimeric muropeptides served
as PBP5 substrates. As expected, the enzymatic activity
of this full-length PBP5 was completely abolished by pre-
incubating the protein with ampicillin (not shown). Thus,
like its soluble counterpart, PBP5 containing its carboxy-
terminal amphiphatic helix was active against a spectrum
of different substrates, including high molecular mass
peptidoglycan, its soluble degradation products and pep-
tidoglycan precursors (Table 2). We conclude that the
soluble and membrane-bound forms of PBP5 recognize
the same range of substrates and that PBP5 does not
discriminate between muropeptides derived from different
sources (i.e. from the sacculus, lipid-II, UDPMurNAc-
pentapeptide or ampicillin).
Although the soluble (non-membrane-bound) form of
PBP5 (PBP5CD18) exhibited full enzymatic activity, it did
not complement the morphological aberrations in E. coli
strains lacking endogenous PBP5 (see above). It was
possible that if PBP5 were not anchored to the membrane
then the protein might not be able to perform its proper
D,D-carboxypeptidase activity in vivo. For example, the
peptidoglycan layer is stretched by osmotic pressure in
living cells whereas isolated sacculi are fully relaxed, and
this might make the substrate inaccessible to PBP5CD18.
Alternately, PBP5CD18 might not be able to reach pen-
tapeptide attached to nascent glycan strands in live cells
if these substrates were concealed by peptidoglycan syn-
thetases in the divisome. To address these questions, we
compared the amounts of pentapeptide remaining in
sacculi of the D,D-carboxypeptidase-deﬁcient strain E.
coli CS703-1 in which we expressed no PBP5 (vector
control), wild-type PBP5 (from pLP515), inactive PBP5
(PBP5S44G from pLP514), or soluble, periplasmic, non-
membrane-bound PBP5 (PBP5CD18 from pLP528)
(Fig. 9B). Soluble, periplasmic, non-membrane-bound
PBP5 digested pentapeptides just as efficiently as wild-
type PBP5, while inactive PBP5S44G exhibited no
activity. We conclude that the inability of PBP5CD18 to
complement the morphological defects of E. coli CS703-1
cannot be explained by the inability to access its sub-
strates in vivo. Therefore, because the anchorless protein
is otherwise fully active, the proper localization and physi-
ological function of PBP5 must depend on its ability to
bind the outer face of the inner membrane as well as on its
enzymatic activity.
Discussion
Cellular localization of PBP5
We report that PBP5 localizes to the cylindrical cell wall of
E. coli, to sites of ongoing cell division and to nascent
division sites before constriction is visible. Furthermore,
the mechanism by which PBP5 is localized, especially at
developing septa, depends on the presence of pentapep-
tide substrates in the wall, on a functional active site in the
enzyme, and on the attachment of periplasmic PBP5 to
the outer face of the inner membrane. Finally, the data
strongly suggest that the normal cellular morphology of E.
coli requires not only that PBP5 be active but also that it
is properly localized to the division site.
Several strands of evidence support the contention that
PBP5 localization is driven by the presence of its pen-
tapeptide substrate. New peptidoglycan-building units,
the GlcNAc-MurNAc-pentapeptides, are inserted in dis-
persed fashion into the old peptidoglycan layer in the
cylindrical part of the cell during elongation, whereas new
cell poles are composed only of newly inserted material
(de Pedro et al., 1997). This means that the concentration
of pentapeptide precursors is much higher at the division
site than that in the cylindrical part of the cell wall. The
localization of PBP5 mirrored this distribution, in particular
its high concentration at newly forming septa. Of course,
such a pattern might be driven by protein–protein interac-
tions, but several additional observations argue against
this possibility. First of all, the active site mutant
PBP5(S44G) did not localize speciﬁcally to midcell posi-
tions even in the presence of pentapeptide substrates.
Because the active site is embedded within the globular
domain of PBP5, it is highly unlikely that the mutation
altered any putative protein–protein interactions. There-
fore, the inability to localize to the septum is best
explained by the inability to covalently bind and hydrolyze
its substrate.
Second, in spherical cells, in which peptidoglycan syn-
thesis in the cylindrical portion of the cell wall is inhibited,
PBP5 moves from its normal position in the lateral wall
and accumulates at division planes, which are the only












b synthesized by PBP1B 59 38
a. Muropeptides and isolated sacculi were from strain D456 that is
enriched in pentapeptides. Buffer was 50 mM sodium Phosphate pH
6.0 and 0.05% T X-100.
b. Newly synthesized murein was made by PBP1B with lipid II as
substrate.
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suggests that PBP5 localization is determined to a large
extent by where its substrate is being inserted. It is note-
worthy that this redistribution of PBP5 occurs either when
a temperature-sensitive PBP2 protein is inactivated or
when the enzymatic activity of wild-type PBP2 is inhibited,
thus reducing the likelihood that PBP5 interacts with
PBP2 or with any other protein engaged in lateral cell wall
elongation.
A third line of evidence is that in cells in which different
stages of cell division are inhibited, PBP5 accumulates at
sites of pentapeptide synthesis and insertion. Two types
of septal peptidoglycan synthesis can be discriminated:
preseptal peptidoglycan synthesis that requires the pres-
ence of an FtsZ ring but not a mature divisome (Nanninga,
1991; de Pedro et al., 1997; Ishidate et al., 1998; Varma
and Young, 2004; 2009; Varma et al., 2007), and the
subsequent synthesis of new cell poles by the combined
activities of PBP3 and PBP1B (Bertsche et al., 2006). In
the ﬁrst type, peptidoglycan synthesis is initiated by the
polymerization of FtsZ at midcell well before a septal
constriction is visible (Den Blaauwen et al., 1999). We ﬁnd
that PBP5 localization at midcell depends on the pres-
ence and activity of FtsZ but not on the presence of FtsA
at this stage. The second type of peptidoglycan synthesis
is inhibited by aztreonam, which acts on the divisome
protein PBP3, or by inactivation of temperature-sensitive
mutants of PBP3. Inhibiting PBP3 reduces the amount of
peptidoglycan insertion at midcell, and in such cells a thin
band of PBP5 still accumulates at stalled division sites,
consistent with the deﬁciency of pentapeptides in these
areas. The localization of PBP5 at midcell in these ﬁla-
ments must be driven by the appearance of pentapep-
tides created by FtsZ-supported glycan strand synthesis.
Furthermore, in ﬁlaments created by growing cells in the
presence of aztreonam for two MDs, division at midcell is
aborted but FtsZ initiates two new Z-rings at the one-
quarter and three-quarter length positions of these cells,
and neither of the new FtsZ rings contain any accompa-
nying PBP3 (Den Blaauwen et al., 2003; Bertsche et al.,
2006). However, bands of PBP5 still relocate to these
future division sites, supporting the notion that PBP5
localizes because of FtsZ-supported glycan strand
synthesis. Overall, the results indicate that protein–
protein interactions with components of the mature divi-
some are not required for PBP5 localization, and provide
substantial evidence that PBP5 localization is driven by
the presence of its substrate.
Substrate-driven localization of PBPs from other
organisms
The dependence of PBP5 localization on the presence of
its substrate is paralleled by the behaviour of a few PBPs
in other organisms. The Class A PBP2 of Staphylococcus
aureus localizes at the septum of this spherical gram
positive bacterium (Pinho and Errington, 2003), but inhib-
iting the transpeptidase activity of PBP2 by the addition of
oxacillin dislodges PBP2 from the septum and spreads it
over the entire cell wall (Pinho and Errington, 2005). New
peptidoglycan is still produced under these conditions,
proving that the lack of midcell localization for PBP2 is not
due to the absence of its substrate but rather due to the
inability of PBP2 to bind substrate in the presence of
oxacillin. PBP2 localization also becomes dispersed when
the production of septal pentapeptide precursors is inhib-
ited by the addition of cycloserine, further supporting the
idea that PBP2 localization is determined by the presence
of its substrate (Pinho and Errington, 2005). Similarly, in
the American football-shaped bacterium, Streptococcus
pneumonia, the Class A and B PBPs are delocalized from
the central FtsZ-ring in a mutant deﬁcient in PBP3, the
D,D-carboxypeptidase of this organism (Morlot et al.,
2004). PBP3 is normally located everywhere in the cell
wall except at the central division plane, meaning that
pentapeptide substrates will accumulate only at that site.
In the PBP3-deﬁcient mutant, then, pentapeptide sub-
strates are available at many positions other than just at
midcell, and this apparently disrupts the speciﬁc localiza-
tion of high molecular mass PBPs, and cell separation is
severely affected in this organism (Morlot et al., 2004).
Therefore, analogous to what we now show for E. coli
PBP5, substrate availability directs the cellular localiza-
tion of PBP2 in S. aureus and of the Class A and B PBPs
in Streptococcus pneumoniae.
Although the localization of other PBPs has been inves-
tigated in Bacillus subtilis (Scheffers and Pinho, 2005)
and in E. coli (Weiss et al., 1999; Den Blaauwen et al.,
2003; Bertsche et al., 2006), only in case of E. coli PBP3
and PBP1B, has it been established that the proteins do
not require substrate for septal localization (Weiss et al.,
1999; Bertsche et al., 2006). Thus, it is possible that the
localization of other PBPs might also be codependent on
substrate availability. This may help explain the relative
ease with which various redundant PBPs can functionally
replace one another.
Membrane attachment is required for midcell localization
and biological function of PBP5
Although wild-type PBP5 localizes strongly to septal sites,
the soluble form PBP5CD18 (lacking the C-terminal mem-
brane anchor), is evenly distributed and does not localize
to division planes in cell ﬁlaments in which PBP3 is
inhibited. This means that the ability to bind substrate
does not by itself ensure that PBP5 will localize properly.
Instead, PBP5 must be correctly tethered by its amphip-
athic helix to the outer surface of the inner membrane if
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substrate. On the other hand, the PBP5CD18 protein does
localize, although weakly, to midcell positions in cells of
the D,D-carboxypeptidase-deﬁcient strain, CS703-1. This
suggests that the untethered form of PBP5 can still ﬁnd
and bind its substrate if competing proteins are absent. In
short, PBP5 lacking its membrane anchor seems unable
to compete efficiently with other D,D-carboxypeptidases
for substrate, and even if these competitors are absent it
is apparently difficult for PBP5 to access nascent glycan
strands without being properly attached to the inner
membrane.
Not only does a PBP5 mutant lacking its membrane-
binding C-terminus not localize properly, it also does not
complement the morphological aberrations of an E. coli
strain that lacks D,D-carboxypeptidase activity (Nelson
et al., 2002). The simplest interpretation is that membrane
localization of PBP5 is required for its morphological
function. In fact, complementation can be restored to the
anchorless PBP5 mutant by fusing it to the analogous
C-terminus of either PBP6 or DacD, but complementation
is not restored by adding the membrane anchor of PBP4
or an unrelated membrane spanning helix (Nelson et al.,
2002). Therefore, the biological activity of PBP5 is not
determined simply by being attached to the membrane.
Instead, PBP5 must be attached in a particular way. For
example, the PBP5 membrane anchor differs structurally
from that of PBP4. The PBP5 C-terminal anchor forms an
obliquely oriented a-helix (O’Daniel et al., 2010) that pen-
etrates deeper into the membrane compared with the
amphipathic helix of PBP4 (Harris et al., 2002; O’Daniel
et al., 2010), which could explain the functional difference.
Because substrate localization seems to drive PBP5
localization, we speculate that the PBP5 membrane
anchor positions the enzyme so that its substrate
becomes accessible.
As an alternative interpretation, it could be argued that
removing the membrane anchor from PBP5 alters its D,D-
carboxypeptidase activity so that it no longer binds effi-
ciently to the pentapeptide substrate. If so, this might
explain why PBP5 neither localizes properly nor fulﬁls its
morphological function. Our results argue against this
alternative. Soluble (anchorless) PBP5 and membrane-
bound PBP5 are equally capable of removing D-alanine
residues from a range of substrates, including the lipid-
bound peptidoglycan precursor lipid II, molecules that
mimic the peptide side chain, and isolated sacculi and
sacculus in the living cell. These observations make it
unlikely that soluble PBP5 has a reduced affinity for
muropeptides. In addition, the lack of substrate speciﬁcity
indicates that the active site of PBP5 does not discrimi-
nate between various types of cross-linked murein (Ste-
fanova et al., 2002), the peptidoglycan layer or nascent
glycan strands. Even so, soluble PBP5 is only marginally
able to complement the D,D-carboxypeptidase-deﬁcient
mutant strain CS703-1, indicating that the problem does
not lie in an enzymatic defect of PBP5. Instead, although
it retains a normal range of enzymatic activity, anchorless
PBP5 is unable to functionally interact with its proper
pentapeptide substrate because it is not positioned appro-
priately on the inner membrane.
Function of PBP5
In vitro, PBP5 has D,D-carboxypeptidase activity in the
absence of other proteins, indicating that interactions with
proteins present in the elongasome or divisome are not
required for its activity. Instead, ongoing glycan strand
synthesis by ClassAand B PBPs during cell elongation or
division seems to be all that is necessary to provide the
substrate on which PBP5 acts. The recently published
crystal structure of PBP1B (Sung et al., 2009) shows that
the transglycosylase reaction occurs relatively close to
the cytoplasmic membrane, whereas the transpeptidation
takes place in the upper most part of the protein. The
active site of PBP5 is approximately located at a distance
of 60 Å from the surface of the cytoplasmic membrane
(Nicholas et al., 2003). During the growth of the nascent
glycan strand before the strand is inserted into the exist-
ing peptidoglycan layer, the pentapeptide substrate will
potentially be available to PBP5 before it reaches the
pentapeptide-binding site of PBP1B about 100 Å from the
membrane surface (Fig. 10). If the hinge region between
the pedestal module II and the enzymatic active domain I
of PBP5 allows free rotation, the protein could even have
access to pentapeptides at different angles of the helically
synthesized glycan strands. A similar line of thought can
be applied to PBP3 in which the transpeptidase domain is
at comparable height to that of PBP1B (Gordon et al.,
2000). Assuming that the Class A and B PBPs are not
protruding through the sacculus but that the peptidogly-
can is stretched above these proteins, PBP5 would not be
able to reach pentapeptides in the existing peptidoglycan
layer and its activity would be limited to the nascent
glycan strands synthesized by the Class A PBP. This
would also explain why PBP5 needs to be membrane-
bound to perform its function. Removal of D-alanines from
the existing peptidoglycan layer as performed by the
soluble PBP5 does not, as we show, assist in maintaining
the correct bacterial shape.
Being properly positioned, then, enables PBP5 to
remove terminal D-alanine residues from the correct posi-
tions of newly synthesized glycan strands, which in turn
regulates of the number and kinds of possible peptide
cross links in the peptidoglycan layer. In contrast, soluble
PBP5 would remove whatever D-alanine it encounters at
random positions on the nascent glycan strands and in
peptidoglycan. This may put the soluble enzyme in direct
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tides required for peptide cross-linking. In fact, overpro-
ducing PBP5 produces spherical growth of E. coli after a
prolonged period of time (Markiewicz et al., 1982),
whereas overproducing the soluble form of PBP5 pro-
duces spherical cells within a few generations (L. Potluri
and K.D. Young, unpublished). Thus, the soluble form of
PBP5 is a more potent inhibitor of cell wall elongation,
consistent with what would be expected if this protein had
access to a greater number of substrates.
In summary, we conclude that the cellular localization
of PBP5 is determined predominantly by sites of active
peptidoglycan synthesis, which provide pentapeptide
substrate that are accessed most efficiently by the
membrane-bound form of PBP5. In turn, this highly spe-
ciﬁc localization of D,D-carboxypeptidase activity to the
developing septum is required for proper maintenance of
cell morphology. Just how and why PBP5 must be local-
ized so speciﬁcally remain questions to be addressed
further.
Experimental procedures
Bacterial strains and growth conditions
All E. coli strains used in this work are listed in Table 3. E. coli
LP9-1 was constructed by P1 transducing the ftsZ84(ts)
mutation into strain CS109, using phage lysate prepared from
E. coli WM1109 (Geissler et al., 2003). E. coli LP10-1 was
constructed by P1 transducing the ftsI23(ts) mutation into
CS109, using phage lysate prepared from E. coli MCI23 (Dai
et al., 1993). Both mutations are linked to the nearby
leu::Tn10 allele. Transductants were selected on Luria-
Bertani (LB) + tetracycline (10 mgm l
-1) plates at 30°C and
screened for ﬁlamentation at 42°C. E. coli LP28-1 carries the
ftsI23(ts) mutation in the CS703-1 background. Interestingly,
Fig. 10. Model showing possible spatial organization of PBP5 and PBP1B with respect to peptidoglycan substrates and products. The crystal
structures of the two PBPs are drawn to scale to one another. The depth of the cytoplasmic membrane (lower grey rectangle) and the location
of the glycan chains (hexagons) are not drawn to scale but merely illustrate their relative locations with regard to the PBPs. Because it does
not reach as high into the periplasm, membrane attached PBP5 could not interact with the existing peptidoglycan layer (upper hexagonal
chain) but instead have access only to pentapeptide substrates (arrows) on the newly synthesized glycan chain (diagonal hexagonal chain).
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normally on LB with 0.5% NaCl at 30°C.
ForimmunolabellingofE.coliLMCstrains,cellsweregrown
to steady state in glucose minimal medium (GB1) containing
6.33 g of K2HPO4.3H2O, 2.95 g of KH2PO4, 1.05 g of
(NH4)2SO4, 0.10 g of MgSO4.7H2O, 0.28 mg of FeSO4.7H2O,
7.1 mg of Ca(NO3)2.4H2O, 4 mg of thiamine, 4 g of glucose
and 50 mg of required amino acids, per litre pH 7.0 at 28°C.
Becauseoftheuseoftemperature-sensitivestrains,28°Cwas
used as standard growth temperature. The strains LMC500,
LMC509, LMC510, LMC512 and LMC582 required lysine, for
growth in minimal medium. LMC509 was grown in a low-salt
glucose minimal medium (1/2 GB1), containing the same
ingredients as GB1 but differing in the amount of salt, which is
3.16 g of K2HPO4.3H2O and 1.48 g of KH2PO4 per liter, pH 7.0.
Cultures were considered to be in steady state of growth if the
ratio between optical density and number of cells remained
constant over time (Fishov et al., 1995). Absorbance was
measured at 450 nm (GB1) or 600 nm (TY) with a 300-T-1
spectrophotometer (Gilford Instrument Laboratories). Cell
number was measured with an electronic particle counter.
Strains CS109 and CS12-7 were grown at 28°C in rich TY
medium containing 10 g bacto-tryptone, 5 g yeast extract, 5 g
NaCl, 15 mmol NaOH per liter or in LB broth supplemented
with 50 mgm l
-1 Kanamycin in the case of sfGFP-PBP5
expression. Strain BL21(DE3) pDACAhis was grown in LB
autoinduction medium that contained per liter 10 g tryptone,
5 g yeast extract, 0.5 g glucose, 2 g a-lactose, 1 mM MgSO4,
3.3 g (NH4)2SO4, 6.8 g KH2PO4 and 7.1 g Na2HPO4. Bacteria
were ﬁlamented by the speciﬁc inhibition of PBP3 (Sykes and
Bonner, 1985) by the addition of 1 mgm l
-1 of aztreonam (ICN,
Biomedicals Ohio) freshly dissolved in saturated Na2CO3.
Spherical growth was achieved by inhibition of PBP2 by
2 mgm l
-1 mecillinam (Park and Burman, 1973; Den Blaauwen
et al., 2003). Both antibiotics were added at an optical density
(OD450) of 0.025, and the cultures were further grown in the
presence of the antibiotic for two MDs. Subsequently, cells
were harvested and ﬁxed for phase contrast imaging and
immunoﬂuorescence labelling as described below.
Flow cytometry
CS703-1 cells carrying appropriate plasmids were grown
overnight at 30°C in LB-Kan medium. Next morning, over-
night cultures were diluted 1:150 in LB-Kan and incubated at
30°C for 2 h, after which IPTG was added to a ﬁnal concen-
tration of 50 mM and incubated further for 1.5 h.At this time all
the cultures reached an OD600 of ~0.4. Cells were harvested
Table 3. Bacterial strains and plasmids.
Relevant characteristics Reference/Source
E. coli Strain
LMC500 (MC4100) F-, araD139, D(argF-lac)U169deoC1, ﬂbB5301, ptsF25, rbsR, relA1, rpslL150, lysA1 (Taschner et al., 1988)
LMC509 MC4100 lysA, ftsZ84(ts) (Taschner et al., 1988)
LMC510 MC4100 lysA, ftsI2158(ts) (Taschner et al., 1988)
LMC512 MC4100 lysA, ftsA12(ts) (Taschner et al., 1988)
LMC531 MC4100 lysA, ftsQ1(ts) (Taschner et al., 1988)
LMC582 MC4100 lysA, pbpa 137 (ts) (Woldringh et al., 1988)
CS109 W1485, F thi glnV (supE) rph-1 rpoS (Denome et al., 1999)
CS12-7 CS109 dacA (Denome et al., 1999)
CS703-1 CS109 derivative that lacks PBPs 1A, 4, 5, 6, 7, AmpC and AmpH (Denome et al., 1999, Meberg
et al., 2001)
D456 Triple deletion of PBP4, 5 and 6 (Edwards and Donachie, 1993)
WM1109 MG1655 ftsZ84(ts) leu::Tn10 (tetR) (Geissler et al., 2003)
PS236 W3110 ftsA12(ts) leu::Tn10 (tetR) (Pichof and Lutkenhaus, 2002)
MCI23 MC4100 ftsI23(ts) leu::Tn10 (tetR) (Dai et al., 1993)
LP9-1 CS109 ftsZ84(ts) leu::Tn10 (tetR) This work
LP10-1 CS109 ftsI23(ts) leu::Tn10 (tetR) This work
LP28-1 CS703-1 ftsI23(ts) leu::Tn10 (tetR) This work
Plasmid
pDACAhis pET28a(+) derivative that encodes MGSSH6SSGLVPRGSHMAS-PBP5(N33-G403) This work
pMLB1113 Medium copy vector, Plac lacI
q, Amp
R (de Boer et al., 1989)




pLP8 pLP4 with mutated HindIII site in Kan
R This work
pLP9 Plac –dsbA(SS)-sfgfp lacI
q Kan
R This work
pPJ5S-SDM Para-dacA-S44G This work
pLP514 Plac –dacA-S44G lacI
q Kan
R This work
pPJ5 Para-dacA (Nelson and Young, 2000)
pLP515 Plac –dacA lacI
q Kan
R This work
pLP521 Plac –dsbA(SS)-sfgfp-dacA lacI
q Kan
R This work
pLP522 Plac –dsbA(SS)-sfgfp-dacA- S44G lacI
q Kan
R This work
pLP523 Plac –dsbA(SS)-sfgfp-dacA-CD18 lacI
q Kan
R This work
pLP524 Plac –dsbA(SS)-sfgfp-dacA-S44G-CD18 lacI
q Kan
R This work
pLP528 Plac –dacA-CD18 lacI
q Kan
R This work
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and resuspended in 1 ml of PBS. These cell suspensions
were diluted 1:10 in PBS and analysed with a FACSCalibur
ﬂow cytometer (BD Biosciences, San Jose, CA) (UAMS ﬂow
cytometry core facility) using the forward scatter and side
scatter settings. CellQuest Pro software was used for the
data acquisition and analysis. The sample size of each
culture was 50 000 cells. CS109/pLP9 and CS703-1/pLP521
cells were used as a guide to draw gate 1 (R1), which rep-
resents normal rod-shaped cells. Gate 2 (R2), representing
abnormal cells, was drawn by using the distribution of
CS703-1/pLP9 cells as a guide, and by excluding the area
covered by gate 1.
Plasmid construction
PfuUltra II Fusion HS DNA polymerase (Stratagene) was
used to amplify polymerase chain reaction (PCR) fragments
for cloning, according to the manufacturer’s instructions.
Standard DNA manipulation techniques were used for
cloning genes into plasmids, and the sequence of each
cloned gene was conﬁrmed by DNA sequencing (MWG
Biotech and by the UAMS DNA Sequencing Facility).
Plasmid pDACAhis was created as follows. A truncated
version of the dacA gene was ampliﬁed by PCR using
primers 5′-CGTGTGAATTCTTTAACCAAACCAGTGATGG
-3′ and 5′-CCGATGCTAGCAATATCAAAACTATGATCCC-3′
and template-DNA from strain MC1061. The PCR product
was cleaved with NheI and EcoRI and ligated into plasmid
pUC19, which had been digested with the same restriction
enzymes. The ligation mixture was transformed into strain
DH5a and a transformant containing the correct plasmid was
selected. The plasmid was isolated, restricted with NheI and
EcoRI, and the fragment containing the dacA gene was
ligated into expression plasmid pET28a(+) (Novagen). The
resulting plasmid pDACAhis was transformed into strain
BL21(DE3), re-isolated, and the correct sequence of the
dacA gene was conﬁrmed. BL21(DE3) pDACAhis allowed
overproduction of cytoplasmic PBP5 with a N-terminal
oligohistidine-tag replacing the signal peptide.
Plasmid pLP4 (Plac lacI
q kan) was created from the medium
copy vector pMLB1113 (Plac lacI
q bla) (de Boer et al., 1989) by
replacing the b-lactamase (bla) gene in pMLB1113 with a
kanamycin resistance gene (kan). The kan gene was ampli-
ﬁed by PCR from pBAD18-Kan with the primers (upstream)
5′-GATGTTACATTGCACAAGAT-3′ and (downstream)
5′-CGCGCTGCTCATGACTCAGCAAAAGTTCGATT-3′, and
the PCR product was digested with BspHI. (The BspHI site is
underlined. Note that pBAD18-Kan carries one BspHI site
upstream of the kan gene so only a single new site needed to
be added.) pMLB1113 was digested with BspHI to remove the
DNA fragment containing the bla gene, and into its place was
ligated the kan gene fragment.
Plasmid pLP9 (Plac-dsbA(SS)-sfgfp lacI
q kan) was created
as follows. First, the HindIII site in the kan gene of pLP4 was
modiﬁed with the QuikChange Lightning Site-Directed
Mutagenesis Kit (Stratagene), by using the primer 5′-
GGAAAGAAATGCATAAACTTTTGCCATTCTCACC-3′ and
its reverse complement. The resulting plasmid (pLP8) carried
the kan gene with a silent mutation (underlined) at codon 184
(lysine), which eliminated an internal HindIII site so that a
single HindIII sequence remained in the multiple cloning site.
Next, the dsbA(SS)-sfgfp gene fusion from pTB263 (T. Bern-
hardt, personal communication) was cloned between the
EcoRI and HindIII sites of pLP8 to give plasmid pLP9. This
plasmid served as the backbone for creating the N-terminal
sfgfp gene fusions described below. The sfgfp construct
encodes the dsbA signal sequence (SS) at its 5′ end, which
allows the translocation of sfGFP from cytoplasm to the peri-
plasm (T.G. Bernhardt, personal communication).
Plasmid pLP514 (Plac-dacA-S44G lacI
q kan) was created by
inserting a DNA fragment containing the dacA-S44G mutant
gene into pLP4 between the BamHI and PstI sites, placing
the mutant PBP 5 gene under control of the lac promoter. The
dacA-S44G DNAfragment was obtained by digesting pPJ5S-
SDM (Para-dacA-S44G) with BamHI and PstI (L. Potluri and
K.D. Young, unpublished).
Plasmid pLP515 (Plac-dacA lacI
q kan) was created by
cloning the wild-type dacA gene from pPJ5 (Para-dacA)
(Nelson and Young, 2000) into the BamHI and PstI sites of
pLP4.
Plasmid pLP521 (Plac-dsbA(SS)-sfgfp-dacA lacI
q kan) was
created by cloning the wild-type dacA gene between the
BamHI and HindIII sites of pLP9. The dacA gene was ampli-
ﬁed from pLP515, using the primers (upstream)
5′-GCTGGCGGATCCGATGACCTGAATATCAAAACT-3′
and (downstream) 5′-GCATGCAAGCTTCTTTTTAACCAA
ACCAGTGATGGAA-3′ (the BamHI and HindIII sites are
underlined; bolded sequences represent portions of the
ampliﬁed gene). The resulting DNA fragment does not
encode the original 29 amino acid signal sequence (SS) of
dacA.
Plasmid pLP522 (Plac-dsbA(SS)-sfgfp-dacA-S44G lacI
q
kan) was generated in the same way as pLP521 except that
dacA-S44G was ampliﬁed from pLP514 and inserted into the
BamHI and HindIII sites of pLP9.
Plasmid pLP523 (Plac-dsbA(SS)-sfgfp-dacADC18 lacI
q
kanR) was created by amplifying a DNA fragment lacking the
ﬁnal 54 nucleotides of the dacA gene (dacADC18) from
pLP515, by using the primers (upstream) 5′-GCTGG
CGGATCCGATGACCTGAATATCAAAACT-3′ and (down-
stream) 5′-GCATGCAAGCTTCTTTTTAGTTACCTTCCGG
GATTTC-3′ [the BamHI and HindIII sites are underlined;
bolded sequences represent portions of the ampliﬁed gene;
and a stop codon (italicized TTA) was inserted in front of the
HindIII site]. The PCR fragment was digested and cloned into
the BamHI and HindIII sites of pLP9. The resulting gene
fusion does not encode the last 18 amino acids of PBP5, so




q kanR) was generated in the same way as pLP523
except that dacA-S44G was ampliﬁed from pLP514 and
inserted into the BamHI and HindIII sites of pLP9.
Plasmid pLP528 (Plac-dacADC18 lacI
q kan) was created by
amplifying a DNA fragment lacking the ﬁnal 54 nucleotides of
the dacA gene (dacADC18) from pPJ5 (Nelson and Young,
2000) by using the primers (upstream) 5′-ATGCCATAGCA
TTTTTATCC-3′ (this sequence corresponds to pBAD vector
backbone) and (downstream) 5′-GCATGCAAGCTTCTT
TTTAGTTACCTTCCGGGATTTC-3′ [the HindIII site is under-
lined; the bolded sequence represents the portion of the
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inserted in front of the HindIII site]. The PCR product was
digested with BamHI and HindIII (via sequential digestion)
and cloned into pLP8. The resulting plasmid encodes
wild-type PBP5 without the carboxy-terminal amphipathic
helix.
Expression and puriﬁcation of PBP5 for activity assays
A water-soluble form of PBP5 lacking the carboxy-terminal
amphiphatic helix was produced (1 mg) and puriﬁed (Table
S1) as described previously (Ferreira et al., 1988; van der
Linden et al., 1992).
The membrane-bound form of PBP5 was isolated from the
cytoplasm as follows: three litres of LB autoinduction medium
containing 50 mgm l
-1 kanamycin were inoculated with 30 ml
of an overnight culture of BL21(DE3) pDACAhis. The cells
were grown for 18 h at 25°C and harvested by centrifugation
at 4°C. The cell pellet was resuspended in 40 ml of 25 mM
Tris/HCl, 10 mM MgCl2, 1 M NaCl, 20% glycerol, pH 7.5. A
small amount of DNase was added and the cells were broken
by sonication with a Branson Digital Soniﬁer operating at 70%
amplitude for 5 min. The cell membranes were pelleted by
ultracentrifugation at 80 000 ¥ g for 60 min at 4°C. The pellet
was extracted with 30 ml of 25 mM Tris/HCl, 10 mM MgCl2,
1 M NaCl, 20% glycerol, 2% Triton X-100, pH 7.5 for 16 h at
4°C. The supernatant obtained after another ultracentrifuga-
tion was supplemented with 20 mM imidazole and incubated
with 5 ml Ni-NTA superﬂow beads for 16 h at 4°C. The beads
were settled in a gravity column and washed with 100 ml of
25 mM Tris/HCl, 10 mM MgCl2, 1 M NaCl, 20% glycerol,
0.2%, Triton X-100, 20 mM imidazole, pH 7.5. Retained pro-
teins were eluted with 25 ml of 25 mM Tris/HCl, 10 mM
MgCl2, 1 M NaCl, 20% glycerol, 0.2%, Triton X-100, 400 mM
imidazole, pH 7.5. The protein was then dialysed to remove
the imidazole.
For removal of the oligohistidine tag, 20 U of thrombin was
added and dialysis continued for 24 h against 25 mM Tris/
HCl, 10 mM MgCl2, 1 M NaCl, 20% glycerol, pH 7.5. Quanti-
tative removal of the oligohistidine tag was conﬁrmed by
SDS-PAGE analysis. The protein was dialysed against
10 mM sodium acetate, 10 mM MgCl2, 500 mM NaCl, 20%
glycerol, pH 4.8, followed by 1:5 dilution with dialysis buffer
lacking NaCl but containing 0.2% Triton X-100. The protein
was applied to a 1 ml High Trap SP HP column (GE Health
Care) at a ﬂow rate of 0.5 ml min
-1 using an ÄKTA prime
FPLC machine. A 60 min gradient from buffer A (10 mM
sodium acetate, 10 mM MgCl2, 100 mM NaCl, 0.2% Triton
X-100, pH 4.8) to buffer B (10 mM sodium acetate, 10 mM
MgCl2, 2 m NaCl, 0.2% Triton X-100, pH 4.8) was applied and
1.5 ml fractions was collected and analysed by SDS-PAGE.
Fractions containing PBP5 were combined. The sample was
dialysed against 25 mM HEPES, 10 ml MgCl2, 500 mM NaCl,
20% glycerol, pH 7.5 and stored at -20°C.
Antibody production and puriﬁcation
One mg of the puriﬁed water-soluble form of PBP5 lacking
the carboxy-terminal amphiphatic helix was sent to the
Centre d’Economie Rurale (Marloie, Belgium) to raise
antibodies. Four subcutaneous injections of a rabbit were
made at days 1, 14, 28 and 56, and antiserum was recovered
80 days after the ﬁrst injection.
Puriﬁed PBP5 protein was separated by SDS-PAGE and
transferred to a nitrocellulose membrane. The membrane
was blocked with 5% skim milk for 4 h and incubated over-
night with 100 ml antiserum at 4°C. Subsequently, the mem-
brane was washed three times for 5 min with PBS and
incubated for 10 min while vigorous shaking with 60 mlo f
0.1 M glycine (pH 2.5). The pH of the solution was neutralized
with the addition of 8 ml 1 M Tris (pH 9.5). For storage, 5%
BSA was added to the eluted affinity-puriﬁed antibodies.
To eliminate cross-reactivity of the affinity-puriﬁed antise-
rum, especially with the PBP6 and PBP6B/DacD proteins, the
antiserum was absorbed against a total protein content
extracted from a mutant strain (CS12-7) that does not
produce the PBP5 protein. In brief, E. coli CS12-7 was grown
overnight in TY medium. The culture was collected by cen-
trifugation and resuspended in 1/5 volume of 0.9% NaCl and
transferred to ice for 5 min. Acetone (-20°C) was added to
the chilled cell suspension and the precipitate was allowed to
sediment for 30 min. Next, the precipitate was collected by
centrifugation at 10 000 ¥ g, for 10 min. The residue was
subsequently suspended in fresh acetone (-20°C), mixed
vigorously, and allowed to sediment for 10 min and collected
by centrifugation 13 000 ¥ g for 5 min. The precipitate was
transferred to a clean ﬁlter paper, spread and air-dried at
room temperature. The affinity-puriﬁed antiserum against
PBP5 was incubated with the precipitate for 4 h at 4°C (1/10
v/v), and centrifuged at maximum speed for 5 min. The super-
natant was used as a source of antibodies in the immunola-
belling experiments.
Fixation and permeabilization of cells
Escherichia coli cells were ﬁxed in 2.8% formaldehyde and
0.04% glutaraldehyde in growth medium. After 15 min of
incubation at room temperature the cells were collected at
8.000 ¥ g for 5 min and washed twice in PBS. Fixed cells
were permeabilized by the addition of 0.1% Triton X-100 in
PBS and incubated for 45 min at room temperature. All fol-
lowing centrifugations were performed at 4.500 ¥ g. The cells
were washed three times in PBS and incubated in PBS
containing 100 mgm l
-1 lysozyme and 5 mM EDTA for 45 min
at room temperature. Finally, the cells were washed three
times in PBS.
Immunolocalization experiments
Escherichia coli cells were labelled with puriﬁed antibodies
against PBP5 as described by den Blaauwen et al. (Den
Blaauwen et al., 2003). In brief, ﬁxed and permeabilized cells
were incubated at 37°C with 0.5% (w/v) blocking reagents
(Boehringer) diluted in PBS. After 30 min of incubation, anti-
bodies against PBP5 diluted in blocking buffer (1/15 v/v) were
added to the cells and further incubated for 60 min at 37°C.
The cells were washed three times with PBS containing
0.05% (v/v) Tween-20. Next, the cells were incubated for
30 min at 37°C with secondary antibody Cy3-conjugated
Donkey Anti-Rabbit IgG (Jackson ImmunoResearch Labora-
PBP5 localizes at peptidoglycan synthesis sites 319
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 300–323tories, USA). The cells were washed again three times in
Tween-20-PBS and resuspended in PBS.
Microscopy and image analysis
For immunolocalization imaging the cells were immobilized
on 1% agarose (Koppelman et al., 2004), and photographed
with a CoolSnap fx (Photometrics) CCD camera mounted on
an Olympus BX-60 ﬂuorescence microscope through an
UPLANFl 100x/1.3 oil objective (Japan). Images were taken
using the program ‘Object-Image2.19 by Norbert Vischer
(University of Amsterdam, http://simon.bio.uva.nl/Object-
Image/object-image.html), which is based on National Insti-
tutes of Health Image-J by Wayne Rasband. In all
experiments the cells were ﬁrst photographed in the phase
contrast mode, then with the Cy3 ﬁlter (U-MNG, ex. 530–
550 nm). Next, the two photographs were stacked and the
length and diameter of the cells were determined from the
phase contrast images and the localization and intensity of
the ﬂuorescence signal was analysed in the ﬂuorescence
images of bacteria as described (Den Blaauwen et al., 2003;
Bertsche et al., 2006). The ﬂuorescence proﬁles of the cells
were analysed using the public domain program ‘Object-J
0.98a’ by Norbert Vischer (University of Amsterdam, http://
simon.bio.uva.nl/objectj/), which is based on image-J by
Wayne Rasband. The map of proﬁles macro is used to create
the average ﬂuorescence proﬁle of the indicated number of
cells plotted against the normalized cell length. From each
cell’s axis marker, a band selection in the ﬂuorescence
channel with ﬁxed line width of 20 pixels is created. For
example, one cell with an axis length of 3 mm = 47 pixels,
which created a proﬁle array of 47 elements, each containing
the mean value of 20 pixels perpendicular and symmetric to
the axis. The array was resampled from 47 with interpolation
to a length of 100 elements. Resampling can be done either
with normalize Proﬁle = true (keeping the peaks at same
height as is done throughout the manuscript) or with normal-
ize Proﬁle = false (keeping the sum of all elements constant).
The proﬁles for all cells are added and divided by the number
of cells to obtain the average proﬁle. All cells of which the
ﬂuorescence proﬁles are compared with each other were
imaged using the same microscope setting. For optimal com-
parison of the shape of the proﬁles the surface below the
proﬁles have been normalized to 1, unless stated otherwise.
For GFP localization, bacteria were grown overnight at
30°C in LB-Kan and the next day were diluted 1:250 (for
CS703-1) or 1:500 (for CS109) into LB-Kan. After 2 h of
growth at 30°C, isopropyl b-D-thiogalactoside (IPTG) was
added to a ﬁnal concentration of 50 mM to induce expression
of the relevant sfGFP-tagged protein, and the cultures were
incubated for another 110 min (CS109) or 135 min (CS703-
1). When appropriate, aztreonam (1 mgm l
-1) was added
1.15 h (CS109) or 1.5 h (CS703-1) after IPTG induction and
the cultures were incubated for one MD. The temperature-
sensitive strains LP9-1 and LP10-1 were grown in LB with
0.5% NaCl for 2 h, after which 20 mM IPTG was added and
the cells were incubated at the permissive temperature
(30°C) for one MD. The cells were shifted to the non-
permissive temperature (42°C) and incubated further for one
or two MDs. Cells from 0.5 ml of culture were concentrated by
centrifugation at 2500 ¥ g for 30–45 s, after which the pellet
was resuspended in 100–200 ml of LB or LB-aztreonam. A
portion of this suspension (5 ml) was spotted onto a micro-
scope slide coated with 1% agarose and incubated at room
temperature for 10 min to immobilize the cells. Slides were
stored at 4°C before imaging, but for no longer than 1–2 h.
Cells and sfGFP localization were visualized by using a Zeiss
Axio Imager.Z1 microscope ﬁtted with a 100x EC Plan-
Neoﬂuar oil immersion objective (numerical aperture, 1.3).
Cells were photographed with anAxiocam MRm cold charge-
coupled device camera, using a typical exposure time of 2 s
to capture ﬂuorescence images. Live cells were imaged
because PBP5 rings were not very sharp in ﬁxed cells. Live
cells were imaged in most cases because PBP5 rings were
not very sharp in ﬁxed cells. However, the temperature-
sensitive strains LP9-1, LP10-1, LMC531 and LMC510 were
ﬁxed because live cells started to constrict on the agarose
pad while processing the cells for imaging sfGFP-PBP5.
Immunoblotting
Samples were separated on 12% SDS-PAGE and transferred
to nitrocellulose membrane. Membranes were incubated with
antibodies at a dilution of 1:10.000 in Tris Buffered Saline
containing 50 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH
7.5 (TBST). The secondary antibody was goat anti-rabbit IgG
conjugated to horseradish peroxidase (Bio-Rad Laboratories,
France) and used at a dilution of 1:10.000 in TBST. Detection
was performed with a chemiluminescence plus kit of Amer-
sham Sciences followed by exposure to Hyperﬁlm (Amer-
sham Biosciences, UK Limited, England).
PBP5 activity and substrate speciﬁcity assays
In vitro assays with water-soluble PBP5 (PBP5s) were per-
formed in 20 mM MOPS/NaOH pH 7.0 at 37°C as described
(Wilkin et al., 1994). The D,D-carboxypeptidase activity of
PBP5s (soluble PBP5) on lipid II was tested by using a
substrate where the two terminal D-Ala were tritiated.
Enzyme (2.6 mg) was incubated for 1 h at 30°C with
3H-lipid II
in 30 ml 33 mM Tris (pH 7.5) 6.6 mM MgCl2 0.3% decyl-PEG
10% dimethylsulphoxide. The same was done with 4.4 mgo f
the D,D-carboxypeptidase from Actinomadura R39 and
ampicillin-inactivated PBP5s. Substrates and products
were separated by thin layer chromatography and
autoradiographed. The assay showed a clear hydrolysis of
D-Ala–D-Ala bond in lipid II by PBP5s. About 80% of the
substrate was hydrolyzed by both R39 and PBP5s.
For the in vitro assays using membrane-bound PBP5
14C-
GlcNAc-labelled lipid II (1.2 nmol, 14 800 dpm) was incu-
bated with 10 mg PBP5 in reaction buffer (10 mM Tris/
Maleate; 10 mM MgCl2, 50 mM NaCl, 0.2% Triton X-100, pH
6.0) for 1 h at 37°C. A control sample did not contain PBP5.
The reaction was stopped by incubation for 15 min at 37°C in
the presence of 100 mgm l
-1 of ampicillin. The samples were
then incubated for 1 h at 37°C with 60 mg PBP1B that had
been pre-incubated 100 mgm l
-1 of ampicillin to block its
transpeptidation activity. Samples were treated with cellosyl,
reduced with sodium borohydrate and analysed by high-
performance liquid chromatography (HPLC) as described
(Bertsche et al., 2005). Peptidoglycan from strain D456
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(Glauner, 1988). About 50 mg of peptidoglycan was incu-
bated with 10 mg of PBP5 in reaction buffer for 4 h at 37°C. A
control sample did not receive PBP5. The samples were
treated with cellosyl, reduced with sodium borohydrate and
analysed by HPLC as described (Glauner, 1988). Muropep-
tides were released from peptidoglycan of strain D456 and
were incubated with or without PBP5 prior to reduction and
HPLC analysis as described above. Assays with UDP-
MurNAc pentapeptide (Kohlrausch and Höltje, 1991) were
performed as described for LdcA (Templin et al., 1999).
Peptidoglycan isolation from strain CS703-1 expressing
different PBP5 alleles
Escherichia coli CS703-1 containing pLP4, pLP514, pLP515
or pLP528 was grown overnight in LB-Kan at 30°C. Next
morning, overnight cultures were diluted 1:100 in 250 ml of
LB-Kan and incubated at 30°C for 2 h. IPTG was added to
a ﬁnal concentration of 100 mM and incubated for another
3 h. Cells were harvested by centrifugation at 10 000 ¥ g for
10 min at 4°C. The cell pellet was resuspended in 6 ml LB
and the cell suspension was added to 9 ml of boiling 6%
SDS. The samples were incubated in a boiling water bath
for 30 min and then stirred overnight at room temperature.
Next morning, the samples were centrifuged at 176 000 ¥ g
for 30 min at 30°C, using a TLA110 rotor in Beckman
Optima TLX ultracentrifuge. Samples were washed three
times with sterile distilled water and the pellet was resus-
pended in 1.5 ml of 10 mM Tris-HCl (pH 7.0). a-Amylase
was added to a ﬁnal concentration of 100 mgm l
-1 and incu-
bated at 37°C for 2 h, after which pronase was added to a
ﬁnal concentration of 100 mgm l
-1 and the samples were
incubated at 60°C for 2 h. Pronase activity was destroyed
by boiling the samples in 0.5% SDS for 30 min. Samples
were washed three times with sterile distilled water.
Muropeptides were released by cellosyl (kindly provided by
Hoechst, Frankfurt, Germany) and reduced with sodium
borohydride prior to HPLC analysis according to a pub-
lished procedure (Glauner, 1988).
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